Edition:
United States

Krystal Biotech Inc (KRYS.OQ)

KRYS.OQ on NASDAQ Stock Exchange Capital Market

9.60USD
26 Apr 2018
Change (% chg)

$0.25 (+2.67%)
Prev Close
$9.35
Open
$9.25
Day's High
$9.87
Day's Low
$9.25
Volume
5,473
Avg. Vol
3,623
52-wk High
$11.98
52-wk Low
$8.03

Chart for

About

Krystal Biotech, Inc. is a gene therapy company. The Company is engaged in developing and commercializing novel treatments for patients suffering from dermatological diseases. The Company has developed a Skin TARgeted Delivery platform, or STAR-D platform, that consists of a patent pending engineered viral vector based on herpes... (more)

Overall

Beta: --
Market Cap(Mil.): $93.82
Shares Outstanding(Mil.): 10.31
Dividend: --
Yield (%): --

Financials

  KRYS.OQ Industry Sector
P/E (TTM): -- 173.69 32.21
EPS (TTM): -0.79 -- --
ROI: -30.69 -0.70 13.05
ROE: -32.75 -2.69 14.90

BRIEF-Krystal Biotech reports qtrly loss per share $1.26‍​

* Krystal Biotech reports that KB103 received clearance from RAC review and announces third quarter 2017 financial results

Nov 13 2017

BRIEF-Krystal Biotech says KB103 granted orphan drug designation by FDA

* Krystal Biotech’s KB103 granted orphan drug designation by the FDA to treat patients with dystrophic epidermolysis bullosa

Nov 07 2017

Earnings vs. Estimates